Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

We have investigated whether sequence 67 to 74 shared by beta chains of rheumatoid arthritis (RA)-associated HLA-DR molecules imparts a specific pattern of peptide binding. The peptide binding specificity of the RA-associated molecules, DRB1*0401, DRB1*0404, and the closely related, RA nonassociated DRB1*0402 was, therefore, determined using designer peptide libraries. The effect of single key residues was tested with site-directed mutants of DRB1*0401. The results have demonstrated striking differences between RA-linked and unlinked DR allotypes in selecting the portion of peptides that interacts with the 67-74 area. Most differences were associated with a single amino acid exchange at position 71 of the DR beta chain, and affected the charge of residues potentially contacting position 71. The observed binding patterns permitted an accurate prediction of natural protein derived peptide sequences that bind selectively to RA-associated DR molecules. Thus, the 67-74 region, in particular position 71, induces changes of binding specificity that correlate with the genetic linkage of RA susceptibility. These findings should facilitate the identification of autoantigenic peptides involved in the pathogenesis of RA.

[1]  J. Stewart Solid Phase Peptide Synthesis , 1984 .

[2]  F. Sinigaglia,et al.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.

[3]  J. Hansen,et al.  Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Kollman,et al.  An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.

[5]  M. Gefter,et al.  Murine MHC polymorphism and T cell specificities. , 1989, Science.

[6]  T. Glant,et al.  Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. , 1987, Arthritis and rheumatism.

[7]  M S Doscher,et al.  Solid-phase peptide synthesis. , 1977, Methods in enzymology.

[8]  P. Bacon,et al.  Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones , 1990, The Journal of experimental medicine.

[9]  A. Kang,et al.  Autoimmunity to type II collagen an experimental model of arthritis , 1977, The Journal of experimental medicine.

[10]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[11]  R. Walsky,et al.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Z. Nagy,et al.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.

[13]  F. Sinigaglia,et al.  Selection of T cell epitopes and vaccine engineering. , 1991, Methods in enzymology.

[14]  P. Gregersen,et al.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[15]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[16]  P. Marrack,et al.  T cell tolerance by clonal elimination in the thymus , 1987, Cell.

[17]  G. Salama,et al.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. , 1993, The Journal of clinical investigation.

[18]  D. Stage,et al.  HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. , 1989, Arthritis and rheumatism.

[19]  A. Sette,et al.  Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide , 1995, The Journal of experimental medicine.

[20]  M. Yaron,et al.  Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. , 1982, Annals of the rheumatic diseases.

[21]  F. Sinigaglia,et al.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.

[22]  Y. Uematsu,et al.  Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells , 1988, Nature.